All that IDEA needs for the stock to be a homerun is for just one of its incubated businesses to succeed and Sanguine is kicking butt. The catalyst is that no one knows about this company, it just had its first-ever SA article written about it, NAV continues to rise and the minimum stock price for selling stock also rises. That said, they never sell stock anyways ......
"I'm reading a lot on this one, however I'm having difficulty discerning any near-term catalysts. Are there any? Or is this simply a raw speculation play with what seems to be a decent business model in a fantastic geographic location for their sector?"
News 
Market Data 
Discover 
